Literature DB >> 8605344

Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome.

J H Pruitt1, M B Welborn, P D Edwards, T R Harward, J W Seeger, T D Martin, C Smith, J A Kenney, R I Wesdorp, S Meijer, M A Cuesta, A Abouhanze, E M Copeland, J Giri, J E Sims, L L Moldawer, H S Oldenburg.   

Abstract

Plasma interleukin-1 (IL-1) activity is modulated in part through the simultaneous appearance of several inhibitors of IL-1 action, including interleukin-1 receptor antagonist (IL-1ra) and the soluble IL-1 type II receptor (IL-1RII). However, little is known concerning the plasma appearance of these inhibitors in patients following operative trauma or those with sepsis syndrome. In the present report, plasma IL-1beta, IL-1ra, and soluble IL-1RI and IL-1RII concentrations were evaluated in 118 patients with sepsis syndrome or after elective operative trauma. Plasma concentrations of IL-1ra increased significantly following elective operative repair of thoraco-abdominal and abdominal aortic aneurysms, and after bowel resection for inflammatory bowel disease, but did not increase after laparoscopic cholecystectomy. Plasma IL-1ra levels were also elevated in patients with sepsis syndrome. In contrast, soluble IL-1RII levels were only increased in patients after operative repair of thoraco-abdominal aortic aneurysms and in sepsis syndrome, whereas concentrations were unaffected by the other more modest surgical procedures. Plasma IL-1RI concentrations decreased in all postoperative patients in the first 24 hours after surgery. We conclude that both plasma IL-1ra and soluble IL-1RII concentrations often increase in sepsis and following some operative trauma. Less severe operative trauma increases the plasma concentration of only IL-1ra, whereas both IL-1ra and soluble IL-1RII are increased in patients with sepsis syndrome or following thoraco-abdominal aneurysm repair.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605344

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  The soluble tumor necrosis factor receptor I is an early predictor of local infective complications after colorectal surgery.

Authors:  Robert Slotwiński; Waldemar L Olszewski; Andrzej Chaber; Maciej Slodkowski; Marzanna Zaleska; Ireneusz W Krasnodebski
Journal:  J Clin Immunol       Date:  2002-09       Impact factor: 8.317

2.  Leucocyte response and anti-inflammatory cytokines in community acquired pneumonia.

Authors:  U K Kolling; F Hansen; J Braun; L Rink; H A Katus; K Dalhoff
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

3.  Development of a genomic metric that can be rapidly used to predict clinical outcome in severely injured trauma patients.

Authors:  Alex G Cuenca; Lori F Gentile; M Cecilia Lopez; Ricardo Ungaro; Huazhi Liu; Wenzhong Xiao; Junhee Seok; Michael N Mindrinos; Darwin Ang; Tezcan Ozrazgat Baslanti; Azra Bihorac; Philip A Efron; Joseph Cuschieri; H Shaw Warren; Ronald G Tompkins; Ronald V Maier; Henry V Baker; Lyle L Moldawer
Journal:  Crit Care Med       Date:  2013-05       Impact factor: 7.598

4.  Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism.

Authors:  T G Gleason; C W Houlgrave; A K May; T D Crabtree; R G Sawyer; W Denham; J G Norman; T L Pruett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients.

Authors:  Sebastian Niedźwiecki; Tomasz Stepień; Krzysztof Kuzdak; Henryk Stepień; Roman Krupiński; Daniel Seehofer; Nada Rayes; Frank Ulrich
Journal:  Langenbecks Arch Surg       Date:  2007-12-07       Impact factor: 3.445

6.  Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial.

Authors:  Susanne Herroeder; Sabine Pecher; Marianne E Schönherr; Grit Kaulitz; Klaus Hahnenkamp; Helmut Friess; Bernd W Böttiger; Harry Bauer; Marcel G W Dijkgraaf; Omarcel G W Dijkgraaf; Marcel E Durieux; Markus W Hollmann
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

7.  Changes in immune parameters and their correction in human cases of tick-borne encephalitis.

Authors:  A V Atrasheuskaya; T M Fredeking; G M Ignatyev
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

8.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

9.  Sepsis-induced human lymphocyte apoptosis and cytokine production in "humanized" mice.

Authors:  Jacqueline Unsinger; Jacquelyn S McDonough; Leonard D Shultz; Thomas A Ferguson; Richard S Hotchkiss
Journal:  J Leukoc Biol       Date:  2009-04-15       Impact factor: 4.962

10.  Levels of inhibitors of tumor necrosis factor alpha and interleukin 1beta in urine and sera of patients with urosepsis.

Authors:  D P Olszyna; J M Prins; B Buis; S J van Deventer; P Speelman; T van der Poll
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.